Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of 0.1% Tacrolimus Ointment in Atopic Dermatitis
NCT00560378Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 1998
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of Tacrolimus Ointment 0.1% Iwaki in atopic dermatitis (AD), sponsored by Astellas Pharma. Started Jun 1998; status: completed.
02
Drugs
Tacrolimus Ointment 0.1% Iwaki
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00560378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00560378.